|
|
||||||||
The Journal of Immunology, Vol 150, Issue 7 2698-2705, Copyright © 1993 by American Association of Immunologists
ARTICLES |
L Ozmen, G Gribaudo, M Fountoulakis, R Gentz, S Landolfo and G Garotta
F. Hoffmann-La Roche Ltd, Pharmaceutical Research-New Technologies, Basel, Switzerland.
With the purpose to use a soluble receptor as an IFN gamma antagonist in vivo, we assessed the immunogenicity, the half-life, the bioavailability, and the activity of the soluble receptor after injection into mice. No significant immunogenicity was detected after multiple chronic injections of mouse (Mo)IFN gamma-R or injections of MoIFN gamma-R in emulsion with CFA. Pharmacokinetic experiments using radiolabeled MoIFN gamma-R revealed that the half-life of the soluble MoIFN gamma-R is 3 h in the blood and 6 h in the lymphoid organs. When the MoIFN gamma-R protein was traced by the capacity of the animal sera to displace the binding of radiolabeled MoIFN gamma-R from affinity purified rabbit anti-MoIFN gamma-R antibodies, a blood half-life of 1 h was determined. Finally, the capacity of the injected receptor to bind and neutralize the IFN gamma-mediated antiviral activity was assessed in vivo. Treatment with IFN-gamma or IFN-alpha A/D protected the mice from the lethal infection with encephalomyocarditis virus. Mice treated with MoIFN-gamma-R neutralized the protective effect of IFN-gamma.
This article has been cited by other articles:
![]() |
K. C. Chadha, J. L. Ambrus Jr., W. Dembinski, and J. L. Ambrus Sr. Interferons and Interferon Inhibitory Activity in Disease and Therapy Experimental Biology and Medicine, April 1, 2004; 229(4): 285 - 290. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Adachi and M. Tsujimoto FEEL-1, a Novel Scavenger Receptor with in Vitro Bacteria-binding and Angiogenesis-modulating Activities J. Biol. Chem., September 6, 2002; 277(37): 34264 - 34270. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Adachi and M. Tsujimoto Characterization of the Human Gene Encoding the Scavenger Receptor Expressed by Endothelial Cell and Its Regulation by a Novel Transcription Factor, Endothelial Zinc Finger Protein-2 J. Biol. Chem., June 28, 2002; 277(27): 24014 - 24021. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-S. Han, Y. Chen, T. Ezashi, and R. M. Roberts Antiviral activities of the soluble extracellular domains of type I interferon receptors PNAS, May 3, 2001; (2001) 111139598. [Abstract] [Full Text] |
||||
![]() |
T. Murase, N. Kume, H. Kataoka, M. Minami, T. Sawamura, T. Masaki, and T. Kita Identification of Soluble Forms of Lectin-Like Oxidized LDL Receptor-1 Arterioscler. Thromb. Vasc. Biol., March 1, 2000; 20(3): 715 - 720. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Gronowski, D. M. Hilbert, K. C. F. Sheehan, G. Garotta, and R. D. Schreiber Baculovirus Stimulates Antiviral Effects in Mammalian Cells J. Virol., December 1, 1999; 73(12): 9944 - 9951. [Abstract] [Full Text] |
||||
![]() |
F. Nicoletti, P. Zaccone, R. Di Marco, M. Lunetta, G. Magro, S. Grasso, P. Meroni, and G. Garotta Prevention of Spontaneous Autoimmune Diabetes in Diabetes-Prone BB Rats by Prophylactic Treatment with Antirat Interferon-{gamma} Antibody Endocrinology, January 1, 1997; 138(1): 281 - 288. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Tan, S. Braun, H. Rong, R. DiGiacomo, E. Dolphin, S. Baldwin, S. K. Narula, P. J. Zavodny, and C.-C. Chou Characterization of Recombinant Extracellular Domain of Human Interleukin-10 Receptor J. Biol. Chem., May 26, 1995; 270(21): 12906 - 12911. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fountoulakis, C. Mesa, G. Schmid, R. Gentz, M. Manneberg, M. Zulauf, Z. Dembic, and G. Garotta Interferon [IMAGE] Receptor Extracellular Domain Expressed as IgG Fusion Protein in Chinese Hamster Ovary Cells J. Biol. Chem., February 24, 1995; 270(8): 3958 - 3964. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-S. Han, Y. Chen, T. Ezashi, and R. M. Roberts Antiviral activities of the soluble extracellular domains of type I interferon receptors PNAS, May 22, 2001; 98(11): 6138 - 6143. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |